How Emotional Granularity Helps Build Resilience in Young and Middle-Aged Colorectal Cancer Survivors
The Role of Emotional Granularity in Enhancing Resilience Among Young and Middle-Aged Colorectal Cancer Survivors: A Mixed-Methods Study
1 other identifier
observational
236
1 country
3
Brief Summary
This study aims to understand how the ability to identify and describe specific emotions (called "emotional granularity") influences coping and adaptation ("resilience") in young and middle-aged colorectal cancer survivors. The main questions to be answer are:
- 1.How does emotional granularity help build resilience during cancer recovery?
- 2.How does emotion regulation contribute to resilience building?
- 3.What specific emotional needs and challenges do survivors experience?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2025
CompletedStudy Start
First participant enrolled
September 30, 2025
CompletedFirst Posted
Study publicly available on registry
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedOctober 1, 2025
September 1, 2025
5 months
September 17, 2025
September 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Level of Resilience
Resilience will be measured by the total score on the Chinese version of the 10-item Connor-Davidson Resilience Scale (CD-RISC-10). Scores range from 0 to 40, with higher scores indicating higher levels of resilience.
Baseline (Day 1, at questionnaire completion for each participant)
Secondary Outcomes (2)
Emotional Granularity Score
Baseline (Day 1, at questionnaire completion for each participant)
Emotion Regulation Difficulties Score
Baseline (Day 1, at questionnaire completion for each participant)
Other Outcomes (1)
Qualitative Themes on Emotional Needs
Post-questionnaire phase (within approximately 2-6 weeks after baseline, depending on scheduling of interviews)
Study Arms (1)
Young and Middle-Aged CRC Survivors
This single cohort consists of young and middle-aged adult survivors of colorectal cancer. All participants will complete the quantitative survey phase. A subset of participants, purposively sampled based on their survey scores, will then be invited to participate in the qualitative interview phase. There is no intervention administered; this is an observational study examining the relationships between emotional granularity, emotion regulation, and resilience.
Eligibility Criteria
The study population will consist of samples and data obtained from three major regional tertiary hospitals in Suzhou, Jiangsu Province: 1. The First Affiliated Hospital of Soochow University: A leading comprehensive tertiary Grade A hospital and a major clinical, teaching, and research center in the region. 2. The Second Affiliated Hospital of Soochow University: Another key comprehensive tertiary Grade A hospital providing high-level medical services to the urban population. 3. Kunshan First People's Hospital Affiliated to Jiangsu University: A premier tertiary Grade A hospital representing the high-quality healthcare infrastructure of county-level cities within the Suzhou administrative area. This selection encompasses top-tier medical institutions from both the central urban district of Suzhou and a developed county-level city (Kunshan), ensuring a representative and diverse sample of the patient population and healthcare delivery within the Suzhou region.
You may qualify if:
- Young and middle-aged adult patients (age in the range of 18-60 years);
- Patients diagnosed with CRC;
- Patients have completed primary treatments (e.g., surgery, chemotherapy, and/or radiotherapy) without experiencing a recurrence of CRC;
- Patients able to use a smartphone and agree to participate in the study.
You may not qualify if:
- Patients who have not been informed of their cancer diagnosis due to family decision to withhold information;
- Patients suffering from severe conditions that may affect participation or assessment, such as significant cognitive impairment, psychiatric disorders, or communication disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Kunshan First People's Hospital Affiliated to Jiangsu University
Suzhou, Jiangsu, 215000, China
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215000, China
The First Affiliated Hospital of Soochow University
Suzhu, Jiangsu, 215000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 17, 2025
First Posted
October 1, 2025
Study Start
September 30, 2025
Primary Completion
March 1, 2026
Study Completion
April 1, 2026
Last Updated
October 1, 2025
Record last verified: 2025-09